The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats.
about
Therapeutic potential of the renin angiotensin system in ischaemic strokeCandesartan, an angiotensin II AT₁-receptor blocker and PPAR-γ agonist, reduces lesion volume and improves motor and memory function after traumatic brain injury in mice.Protein kinase C inhibition attenuates vascular ETB receptor upregulation and decreases brain damage after cerebral ischemia in ratEffect of chronic alcohol consumption on brain damage following transient focal ischemiaPostischemic administration of angiotensin II type 1 receptor blocker reduces cerebral infarction size in hypertensive rats.Candesartan induces a prolonged proangiogenic effect and augments endothelium-mediated neuroprotection after oxygen and glucose deprivation: role of vascular endothelial growth factors A and B.Human cerebrovascular contractile receptors are upregulated via a B-Raf/MEK/ERK-sensitive signaling pathway.Reduction of cerebral infarct size by dronedarone.Role of central angiotensin receptors in scopolamine-induced impairment in memory, cerebral blood flow, and cholinergic function.Blockade of Central Angiotensin II AT1 Receptor Protects the Brain from Ischemia/Reperfusion Injury in Normotensive Rats.U0126 attenuates cerebral vasoconstriction and improves long-term neurologic outcome after stroke in female ratsUse of enterally delivered angiotensin II type Ia receptor antagonists to reduce the severity of colitis.Acute treatment with candesartan reduces early injury after permanent middle cerebral artery occlusionSequential Therapy with Minocycline and Candesartan Improves Long-Term Recovery After Experimental Stroke.Effect of Long-Term Treatment with Fimasartan on Transient Focal Ischemia in Rat Brain.Neuroprotective effect of an angiotensin receptor type 2 agonist following cerebral ischemia in vitro and in vivo.Mechanisms of acute neurovascular protection with AT1 blockade after stroke: Effect of prestroke hypertension.AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator.Artery reopening is required for the neurorestorative effects of angiotensin modulation after experimental strokeEstrogen prevents intestinal inflammation after trauma-hemorrhage via downregulation of angiotensin II and angiotensin II subtype I receptor.Role of angiotensin receptor blockers in the prevention and management of ischaemic stroke.Potential of the angiotensin receptor blockers (ARBs) telmisartan, irbesartan, and candesartan for inhibiting the HMGB1/RAGE axis in prevention and acute treatment of stroke.Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors?Late cerebral ischaemia after subarachnoid haemorrhage: is cerebrovascular receptor upregulation the mechanism behind?Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage.Vascular plasticity in cerebrovascular disorders.The role of angiotensin II receptors in stroke protection.The protective arms of the renin-angiontensin system in stroke.Candesartan reduces the hemorrhage associated with delayed tissue plasminogen activator treatment in rat embolic stroke.Different protective and reparative effects of olmesartan in stroke according to time of administration and withdrawal.The VALUE trial: a commentary.A sartan derivative with a very low angiotensin II receptor affinity ameliorates ischemic cerebral damage.Acute mitogen-activated protein kinase 1/2 inhibition improves functional recovery and vascular changes after ischaemic stroke in rat-monitored by 9.4 T magnetic resonance imaging.Crosstalk between the angiotensin and endothelin system in the cerebrovasculature after experimental induced subarachnoid hemorrhage.Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?A comparative study of neuroprotective effect of single and combined blockade of AT1 receptor and PARP-1 in focal cerebral ischaemia in rat.Brain-Derived Neurotrophic Factor Knockdown Blocks the Angiogenic and Protective Effects of Angiotensin Modulation After Experimental Stroke.Vasomodulatory effects of the angiotensin II type 1 receptor antagonist losartan on experimentally induced cerebral vasospasm after subarachnoid haemorrhage.Enalapril attenuates ischaemic brain oedema and protects the blood-brain barrier in rats via an anti-oxidant action.Inhibition of mitogen-activated protein kinase 1/2 in the acute phase of stroke improves long-term neurological outcome and promotes recovery processes in rats.
P2860
Q28077553-1B888F36-0982-48C4-8C61-97806BB16CEEQ30528431-02890495-0E8B-46FA-A839-11A9A8E2F586Q33268693-BCBD3FCC-1FC1-4972-8922-4C3E93317AEDQ33314497-D32497AA-B07D-454F-93DD-50A769061B58Q33441240-08B50B5F-3B59-49DB-923E-8D0EFFB45CAAQ33603639-68DB6511-1541-4CC5-BF82-7C88FB4CC871Q33790457-5712569D-F141-4BAB-8E9F-938BF4C76940Q34007040-227F18FB-420D-433D-A8EE-02FBFCBFB557Q34169364-0083DE12-B28F-4289-B786-3D7EA900A99CQ34567399-E10E9A33-194C-480D-A67F-E94E47F4B351Q35143502-90D60945-F20F-46BC-A8A3-46E8612A53D1Q35184531-63D045E7-2EA2-446B-B706-8792E3E295E6Q35196887-A6ECF86D-F0FE-44AF-B125-CC1479DA17D9Q36026755-41847D26-A836-469E-81E9-DAE8D38EE2B2Q36095573-923A7B74-5596-4C63-B811-8F9C53CDD572Q36380230-4896072F-5BB4-49AE-8863-614BBC3AE807Q36412546-80358457-96B8-44D0-B288-6B998075CD57Q36573232-B84AE588-2E0E-40DE-9BB8-657F4939D1A8Q36846675-4A413EAC-0E8E-4A84-AB7A-31A44BF4E646Q36977043-E6816FC7-E977-4022-B140-477956F30540Q36979914-68D20981-E777-412E-80EA-0452732DBBBFQ37225236-90AE2AC9-3058-4B7F-8BFC-46588DD718D1Q37600856-6E8D73ED-36C1-40FF-A1AC-E2132990F58EQ37810632-CF04A9DA-7DC9-4887-A39F-425CB66357CAQ37822830-A9C445C6-354F-41FA-B284-A01B9BFC92D5Q37874109-4A293669-E422-4426-B8E4-2608E44748EAQ37996869-9783B843-D288-4711-8421-5BEB3EEA3A3FQ38210926-49085182-ED41-4B1E-9B5C-0658D9304A61Q38592712-04E0DE7A-58DB-4786-B465-B02057B13CFDQ41668994-6495CE96-0A64-4BFA-B158-F0A075B79F79Q45139055-5B1CD9B6-4DE4-4994-85F2-10F22A5CE449Q45964663-B51F99E4-737E-4EA5-BFC2-9A3FAC756F0BQ47621353-CF075D2E-1A89-42F3-AD83-7B9734F11E89Q48056900-0650EEF2-1FD9-4EA9-AD7D-7CE276E5F74EQ48189466-364BB649-0AC7-4FF7-B87B-2394561557A3Q48362472-0FD7E175-5C4A-4849-9498-A4CDE7F3BB9EQ49011342-CDA08201-A777-45D3-8404-F9C0422B48F6Q50041701-DEA2783E-BE19-486E-BAF5-968B57824577Q50225855-88489504-6AA5-4A74-A9D6-089C4096E189Q52146579-3F81F5A9-281B-4FC2-8DCF-BDE50BA7E5BF
P2860
The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats.
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The angiotensin II type 1-rece ...... ent cerebral ischemia in rats.
@ast
The angiotensin II type 1-rece ...... ent cerebral ischemia in rats.
@en
type
label
The angiotensin II type 1-rece ...... ent cerebral ischemia in rats.
@ast
The angiotensin II type 1-rece ...... ent cerebral ischemia in rats.
@en
prefLabel
The angiotensin II type 1-rece ...... ent cerebral ischemia in rats.
@ast
The angiotensin II type 1-rece ...... ent cerebral ischemia in rats.
@en
P2093
P2860
P1476
The angiotensin II type 1-rece ...... ent cerebral ischemia in rats.
@en
P2093
Arnd Doerfler
Christine Okorn
Gerd Heusch
Rainer Schulz
Sophia Goerike
Tobias Engelhorn
P2860
P304
P356
10.1097/00004647-200404000-00012
P577
2004-04-01T00:00:00Z
P5875
P6179
1041111216